Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FE2Q1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,101
Award facts
- Contract value 100% obligated
- $16,101.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,101.26 to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials, with an ultimate completion date of August 26, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Renflexis is a biosimilar to Remicade used in treating inflammatory conditions, and this procurement supports the federal government's medical supply chain requirements through the DLA's pharmaceutical distribution network.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp serves critical medical procurement needs across military and veteran healthcare systems. The IDC vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FE2Q1?
SPE2DB25FE2Q1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FE2Q1 worth?
The government has obligated $16,101 on SPE2DB25FE2Q1.
Is contract SPE2DB25FE2Q1 an order under another contract?
Yes. SPE2DB25FE2Q1 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE2Q1 competed?
The extent of competition for SPE2DB25FE2Q1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award